China can build the factories. It can support the lending. It can announce another package of measures designed to keep growth moving. What it cannot simply order into existence is a household willing to spend—or a foreign government willing to absorb an ever-larger share of Chinese production.
That is the uncomfortable thread connecting weak holiday spending, a retreat in Chinese technology stocks, and Europe’s push to restrict Chinese hybrid vehicle imports. Beijing’s economic machinery is still running. But two of the things it needs most—domestic confidence and access to overseas customers—are looking increasingly unreliable.
Meanwhile, a separate development demands careful attention: the death of a Russian laboratory worker following severe pneumonia has prompted international questions about a possible plague infection. The potential consequences are serious. The evidence, however, remains unresolved.
These stories require different responses. The health case calls for verification rather than panic. The economic picture calls for something Beijing has struggled to deliver: a recovery that reaches households, rather than merely keeping production humming.
Key Takeaways
- The Russian laboratory worker’s death remains unexplained; neither plague infection nor an outbreak has been confirmed.
- Weak holiday spending and pressure on technology valuations weighed on Chinese stocks despite recent economic support.
- PIIE forecasts Chinese growth slowing to 4.6% in 2026 and 4.3% in 2027 as domestic weakness and trade barriers persist.
- Possible EU restrictions on Chinese hybrids could become a test of whether negotiations can address wider trade imbalances.
Table of Contents
- A Suspected Plague Case Is Not a Confirmed Outbreak
- China’s Holiday Spending Failed to Reassure Investors
- The Growth Forecast Exposes Beijing’s Bigger Problem
- Europe Is Targeting China’s Hybrid Vehicle Advantage
- Neither Side Has a Comfortable Exit
A Suspected Plague Case Is Not a Confirmed Outbreak
First, the alarming development—and the distinction that must not get lost beneath the alarming language.
A 28-year-old employee at an anti-plague research institute in Russia’s Irkutsk region died after developing severe pneumonia. Almost 200 contacts were reportedly placed under observation. No plague infections have been confirmed among those contacts, and the worker’s death has not been established as a plague death.
Unconfirmed local accounts suggested she might have encountered plague bacteria after breaking a test tube. Russia’s public health agency disputed the laboratory-accident explanation, saying its investigation found no accident involving dangerous microorganisms and that testing detected no pathogens associated with her work.
Authorities have described the illness as pneumonia of unknown origin. That leaves a troubling unanswered question, not proof of an outbreak.
Chinese Foreign Ministry spokesperson Guo Jiakun said China and Russia maintained close communication on preventing and controlling infectious diseases, including plague. His remarks followed questions about whether Moscow had informed Beijing about the incident.
The institute had recently conducted a joint emergency-response exercise involving Chinese participants. That exercise covered infectious-disease outbreaks and monitoring transmission in border regions. Its timing provides context for the bilateral cooperation, but it does not establish any connection to the worker’s illness.
Irkutsk lies north of Mongolia rather than directly on China’s border. Nevertheless, transport links, including flights and rail services connecting its regional capital with Chinese cities, make cross-border coordination relevant. Mongolia’s health ministry assessed the risk as low while maintaining border health monitoring.
Why the Possibility Still Matters
Pneumonic plague is dangerous because it can spread between people through respiratory droplets during close contact and progress rapidly. The World Health Organization’s plague guidance explains why early diagnosis and treatment are so important: untreated pneumonic plague can be fatal within 18 to 24 hours, with mortality approaching 100% without treatment.
But “without treatment” is doing important work there. Early antibiotic treatment can effectively cure the infection. Rapid diagnosis, isolation and contact tracing are therefore practical safeguards, not administrative formalities.
The WHO has sought further information from Russia. Moscow says it notified the organisation through established procedures and maintains that the epidemiological situation is stable.
There are legitimate reasons to scrutinise official assurances, given Russia’s and China’s records on infectious-disease transparency. Still, scepticism is not a substitute for evidence. Neither an unconfirmed account of a broken test tube nor an unexplained death establishes plague transmission.
The sensible position is straightforward: demand information, monitor the investigation and keep the uncertainty explicit. Treating this as an established outbreak would be getting ahead of the facts.
China’s Holiday Spending Failed to Reassure Investors
The economic story is less mysterious, although hardly more comfortable for Beijing.
Chinese mainland stocks retreated when trading resumed after the National Day holiday. The benchmark CSI 300 finished Thursday’s morning session down 0.4%, reversing an earlier advance. The technology-heavy STAR 50 fell as much as 3.8%, reaching a near six-month low.
The holiday had provided an opportunity for households to demonstrate that domestic demand was recovering. Instead, early Golden Week indicators pointed to muted travel demand, softer spending per person and subdued entertainment activity. Citigroup highlighted a sharp decline in box-office sales.
That combination matters. Travel activity alone does not tell us how comfortable consumers feel. Spending per person helps distinguish between people getting out of the house and people opening their wallets with confidence. The early figures offered little reassurance on the latter.
And this followed a targeted support package announced in late September, including mortgage subsidies and expanded lending to selected industries.
The obvious question was not whether Beijing had done something. It had. The question was whether those measures could produce a sustained recovery, rather than help the government reach its annual growth objective.
Those are not the same achievement.
Stimulus Announcements Are Not Household Confidence
Investors increasingly appear to be separating Beijing’s ability to announce support from its ability to reverse persistent weakness in domestic demand. That is a necessary distinction in an economy still weighed down by a prolonged property downturn and industrial overcapacity.
Attention is turning to the party plenum scheduled for October 26–29 for indications of further support. The finance minister also said in an October 1 article that additional fiscal policies were under consideration.
More measures could help. But their significance will depend on whether they strengthen household spending—not simply on the size or ambition of the announcement. As explored in our analysis of China’s fragile recovery and technology constraints, an encouraging headline does not necessarily resolve the weaknesses underneath it.
The sell-off also had external causes. Rising global bond yields challenged valuations in the popular artificial-intelligence trade, while higher oil prices weakened risk appetite across Asia. Hardware technology shares were particularly exposed: Suzhou TFC Optical Communication fell more than 8%, and Semiconductor Manufacturing International Corporation suffered substantial losses.
So this was not simply a referendum on holiday consumption. It was weak domestic spending meeting a less forgiving global market. Investors had reasons to question both the recovery story and the prices attached to some of its most fashionable stocks.
The Growth Forecast Exposes Beijing’s Bigger Problem
The Peterson Institute for International Economics expects China’s growth to weaken further as domestic problems persist and trade restrictions erode export momentum.
| Year | Chinese GDP growth | Status |
|---|---|---|
| 2025 | 5.0% | Reported growth |
| 2026 | 4.6% | PIIE forecast |
| 2027 | 4.3% | PIIE forecast |
The 2026 forecast is slightly above the institute’s April projection of 4.5%. Its 2027 forecast is unchanged. Beijing’s growth target of 4.5%–5% reflects the increasingly difficult environment.
PIIE senior fellow Karen Dynan pointed to industrial overcapacity and the prolonged property downturn as continuing drags on domestic demand. Exports have provided crucial support, but that support is expected to weaken as trade barriers increase.
China has benefited from supplying goods used in the global AI infrastructure boom. Yet a strong market for those products does not make the country immune to restrictions. Dynan warned that the shifting trade environment could undermine the advantage, while declining to identify particular restrictions because conditions remained fluid.
The quarterly figures already show a loss of momentum. Reported growth slowed from 5% year on year in the first quarter to 4.3% in the second—the weakest quarterly performance since late 2022, during the zero-Covid period.
This is not simply a story of the entire world slowing at the same speed. PIIE forecasts global growth of 3.2% in 2026 and 3.1% in 2027, alongside US growth of 2.3% in 2026, supported by AI investment despite uncertainty surrounding the Iran war and energy prices.
China’s central challenge is therefore specific: can household spending become strong enough to offset weaker exports and the continuing property drag? If not, Beijing remains dependent on foreign demand just as foreign governments become less willing to accommodate it.
Europe Is Targeting China’s Hybrid Vehicle Advantage
That brings us to Europe, where the export problem is becoming painfully concrete.
The European Union is preparing possible restrictions on Chinese hybrid vehicle imports as Trade Commissioner Maroš Šefčovič heads to Beijing for talks with Commerce Minister Wang Wentao. European officials want at least one meaningful concession before an October deadline for progress.
Brussels is looking for more than an automotive compromise. It hopes an agreement to moderate exports in one industry could provide a model for addressing imbalances elsewhere.
Beijing, however, is resisting. The Financial Times reported that China rejected an initial European proposal to limit its share of the EU’s plug-in hybrid market to around 15%, down from more than a third.
The market-share figures show why European officials are concerned. According to Dataforce figures cited by Bloomberg and other outlets, Chinese brands accounted for:
- Nearly 12% of European new-car sales in August.
- Roughly one quarter of hybrid sales.
- About one third of plug-in hybrid sales.
Those figures cover the EU, EFTA countries and the UK—not the EU alone. That geographical distinction matters when comparing them with Brussels’s proposed limit.
Hybrids are particularly important because they do not currently face the additional EU tariffs applied to Chinese battery-electric vehicles. They have consequently become an increasingly significant route into European markets.
A Safeguard, Not Yet a Settled Policy
Brussels is considering temporary safeguard measures, potentially including tariff-rate quotas. Under that approach, imports above a specified volume would attract additional duties.
The proposals remain under discussion and could change depending on the Beijing meetings. They should not be confused with restrictions already in force. The WTO’s overview of safeguards provides useful background on this category of trade measure.
Reports of possible action lifted European automotive shares. Volkswagen rose as much as 4.6%, while Mercedes-Benz gained 2%. Investors evidently saw a prospect of relief for manufacturers facing intensifying Chinese competition.
But the dispute extends well beyond cars. The EU’s goods trade deficit with China exceeds €1 billion a day, and European officials say months of technical negotiations have yielded little evidence of rebalancing.
German Chancellor Friedrich Merz and French President Emmanuel Macron have jointly urged Brussels to develop stronger powers to restrict—or potentially block—imports causing severe or systematic distortions in the single market.
Their proposal does not explicitly name China. Nevertheless, the alignment of Europe’s two largest economies signals growing dissatisfaction with existing trade defenses. It could strengthen Brussels’s negotiating position and support investigations into other sectors, including chemicals. This broader shift is also examined in our coverage of Europe’s hardening approach to China’s export model.
Neither Side Has a Comfortable Exit
Beijing opposes voluntary export restrictions, arguing that they violate WTO rules and undermine fair competition. Chinese officials have shown more willingness to discuss investment and additional purchases of European goods than limits on Chinese exports.
Europe wants improved market access, fewer restrictions affecting brandy, pork and dairy products, and faster approvals for exports of Chinese critical raw materials. Its difficulty is securing those concessions without provoking retaliation against European exporters or disrupting manufacturers dependent on Chinese supplies.
This is why the hybrid dispute matters beyond the showroom. A negotiated agreement would demonstrate that targeted talks can deliver something tangible. Failure would strengthen the argument for broader restrictions, raising risks for investment, supply chains and consumers on both sides.
Veteran China analyst Bill Bishop offered a pointed warning: Beijing might interpret Merz’s political weakness, unrest in France and divisions over EU trade policy as evidence that Europe is bluffing—and will accept a few modest concessions.
That is an assessment of what Chinese leaders might believe, not proof of their thinking. But it identifies the danger neatly. Political divisions do not necessarily mean that Europe’s tolerance for industrial pressure is unlimited.
Beijing’s problem is that it needs export markets while struggling to revive consumption at home. Europe’s problem is that it wants to defend its industries without damaging its own commercial interests. Neither side can make the other’s constraints disappear.
The immediate health uncertainty requires better evidence. The economic uncertainty requires better results. For Beijing, another reassuring statement or another support announcement will not settle the central question: who will buy what China produces?
Frequently Asked Questions
Has pneumonic plague been confirmed in the Russian laboratory case?
No. Authorities have described the worker’s illness as pneumonia of unknown origin. No plague infections have been confirmed among the contacts reportedly placed under observation.
Why is Europe considering restrictions on Chinese hybrids?
Chinese brands have gained substantial hybrid market share, while hybrids do not face the additional EU tariffs applied to Chinese battery-electric vehicles. Brussels is considering safeguards amid wider concerns about industrial competition and trade imbalances.
What is the main risk to China’s growth outlook?
Weak household demand and the property downturn continue to weigh on the economy, while rising trade barriers threaten exports that have helped sustain growth.
